Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) hit a new 52-week low during trading on Monday . The stock traded as low as $11.56 and last traded at $11.59, with a volume of 72522 shares traded. The stock had previously closed at $12.51.
Wall Street Analysts Forecast Growth
ARDT has been the topic of a number of research reports. Royal Bank of Canada cut their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 4th. Mizuho cut their price objective on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Guggenheim started coverage on Ardent Health Partners in a report on Wednesday, April 9th. They set a "buy" rating and a $16.00 target price on the stock. Stephens restated an "overweight" rating and issued a $22.00 target price on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Finally, Morgan Stanley reduced their price target on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $20.58.
Check Out Our Latest Stock Analysis on Ardent Health Partners
Ardent Health Partners Trading Down 0.6 %
The stock's 50 day moving average is $13.34 and its 200-day moving average is $15.35. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.
Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.48 billion. As a group, analysts expect that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. Ventas Inc. bought a new stake in Ardent Health Partners in the 4th quarter worth about $159,570,000. Franklin Resources Inc. purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at about $15,839,000. Segall Bryant & Hamill LLC purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at about $4,478,000. Pier Capital LLC grew its stake in shares of Ardent Health Partners by 70.1% in the fourth quarter. Pier Capital LLC now owns 373,904 shares of the company's stock worth $6,386,000 after acquiring an additional 154,077 shares during the period. Finally, Geode Capital Management LLC purchased a new position in shares of Ardent Health Partners during the third quarter valued at approximately $2,581,000.
Ardent Health Partners Company Profile
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Featured Stories
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.